0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
259.50%
5Y revenue/share CAGR 1.25-1.5x NHC.AX's 195.61%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
67.41%
3Y revenue/share CAGR under 50% of NHC.AX's 143.72%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
336.60%
10Y OCF/share CAGR under 50% of NHC.AX's 2346.27%. Michael Burry would worry about a persistent underperformance in cash creation.
2470.48%
5Y OCF/share CAGR above 1.5x NHC.AX's 358.51%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
1201.06%
3Y OCF/share CAGR above 1.5x NHC.AX's 673.15%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
346.20%
Below 50% of NHC.AX's 833.49%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
581.91%
5Y net income/share CAGR 1.25-1.5x NHC.AX's 435.63%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
1255.61%
3Y net income/share CAGR above 1.5x NHC.AX's 823.43%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-90.46%
Negative equity/share CAGR over 10 years while NHC.AX stands at 13.87%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
13786.42%
5Y equity/share CAGR above 1.5x NHC.AX's 26.01%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
62.08%
3Y equity/share CAGR above 1.5x NHC.AX's 23.20%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1938.37%
3Y dividend/share CAGR above 1.5x NHC.AX's 531.38%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.